Bildkälla: Stockfoto

Proact: Initiatives to Counter Cost Inflation - Redeye

Redeye retains its positive view of Proact despite somewhat reducing our Base Case and 2023-2024 EBITA forecasts. Sales was solid in the quarter, with the highlight being 8% organic growth in recurring revenue. However, cost inflation hurt margins, which Proact has not yet fully compensated for, mostly due to its three years Cloud and Support contracts.

Redeye retains its positive view of Proact despite somewhat reducing our Base Case and 2023-2024 EBITA forecasts. Sales was solid in the quarter, with the highlight being 8% organic growth in recurring revenue. However, cost inflation hurt margins, which Proact has not yet fully compensated for, mostly due to its three years Cloud and Support contracts.
Börsvärldens nyhetsbrev
ANNONSER